TP53 and hepatocellular carcinoma: In liver cancer (HCC), the haploid-insufficient tumour suppressor apoptosis-stimulating of p53 protein 2 (ASPP2), an activator of p53, inhibits tumor growth by negatively regulating the mevalonate pathway.